Mission DiscGenics’ mission is to improve the lives of those debilitated by degenerative diseases of the spine through development of innovative regenerative therapies. We are committed to achieving this mission by delivering high-quality products that meet or exceed customer requirements. This is accomplished by:
Complying with applicable global regulatory requirements and standards
Challenging ourselves to define and evolve Quality Objectives that continually improve our Quality Management System
Maintaining the integrity and effectiveness of the QMS
Applying sound scientific principles to ensure that our products are safe and efficacious
Fostering a culture of quality that promotes integrity, innovation, accuracy and teamwork
Establishing quality as the backbone of all operations!
Description DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.